Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6118533 | International Journal of Antimicrobial Agents | 2009 | 5 Pages |
Abstract
The standard mode of administration of piperacillin treatment is by intermittent infusion. However, continuous infusion may be advantageous as β-lactam antibiotics exhibit time-dependent antibacterial activity. In previous studies, we found a higher rate of clinical cure of ventilator-associated pneumonia (VAP) by continuous infusion rather than intermittent infusion of meropenem and ceftazidime. Therefore, the objective of this historical cohort study was to establish the clinical efficacy of piperacillin/tazobactam (PIP/TAZ) administered by continuous and intermittent infusion in the treatment of VAP in patients without renal failure. Logistic regression analysis showed a higher probability of clinical cure of VAP by continuous compared with intermittent infusion when the microorganism responsible for VAP had a minimum inhibitory concentration (MIC) of 8 μg/mL [8/9 (88.9%) vs. 6/15 (40.0%); odds ratio (OR) = 10.79, 95% confidence interval (CI) 1.01-588.24; P = 0.049] or 16 μg/mL [7/8 (87.5%) vs. 1/6 (16.7%); OR = 22.89, 95% CI 1.19-1880.78; P = 0.03]. Thus, administration of PIP/TAZ by continuous infusion may be considered more effective than intermittent infusion for the treatment of VAP caused by Gram-negative bacteria when the MIC of the microorganism responsible for VAP is 8-16 μg/mL in patients without renal failure.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Leonardo Lorente, Alejandro Jiménez, MarÃa M. MartÃn, José Luis Iribarren, Juan José Jiménez, MarÃa L. Mora,